|
- 积分
- 1
- 威望
- 1
- 包包
- 292
|
When Nature broke the news in December 2011 that Novartis
2 a7 ]( h9 b2 ?. xwas to close its brain research facility in Basel, Switzerland,
& p: w) z( O8 Z/ G+ E! fthe story noted that this move closely followed similar cuts
- m2 C/ q0 v5 G0 e& t( _' ]% Lby rival pharmaceutical firms. As a report from the European College
8 q! x/ x6 a; o8 A5 ]9 Q [3 Uof Neuropsychopharmacology
( m% \- v+ ?- W) _. qhad warned a few months earlier, the* {# `4 _+ r, q( C' B. x
abandonment of research into new psychiatric drugs by AstraZeneca,
9 C: T/ s/ t; I. i2 o+ [GlaxoSmithKline
2 l; g$ P1 `. }1 |5 ?/ hand others meant that “withdrawal of research0 w% a. D1 M" y! W# X7 b
resources is a withdrawal of hope for patients and their families”.
. V; e& @# U) `+ U/ ~ i' D- C, n) T' | d$ J" [( h0 X1 B# Z
1 _- c: O$ r5 n) E+ k" ~回复有免费下载链接
: H6 M; t1 J8 v) @% X
( g2 l1 E; q6 W1 Z+ g" u |
-
总评分: 包包 + 20
查看全部评分
|
发表于 2013-10-12 08:22
发表于 2013-10-12 08:44
